Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
CD180 Biologics Sequence Review Report 2026: CD180 antigen Similarity and Patent-Risk Signals
8 min read
CD180 Biologics Sequence Review Report 2026: CD180 antigen Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CD180 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CCL7 Biologics Sequence Review Report 2026: C-C motif chemokine 7 Similarity and Patent-Risk Signals
8 min read
CCL7 Biologics Sequence Review Report 2026: C-C motif chemokine 7 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CCL5 Biologics Sequence Review Report 2026: C-C motif chemokine 5 Similarity and Patent-Risk Signals
8 min read
CCL5 Biologics Sequence Review Report 2026: C-C motif chemokine 5 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CCL22 Biologics Sequence Review Report 2026: C-C motif chemokine 22 Similarity and Patent-Risk Signals
8 min read
CCL22 Biologics Sequence Review Report 2026: C-C motif chemokine 22 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL22 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CCL3 Biologics Sequence Review Report 2026: C-C motif chemokine 3 Similarity and Patent-Risk Signals
8 min read
CCL3 Biologics Sequence Review Report 2026: C-C motif chemokine 3 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CCL26 Biologics Sequence Review Report 2026: C-C motif chemokine 26 Similarity and Patent-Risk Signals
8 min read
CCL26 Biologics Sequence Review Report 2026: C-C motif chemokine 26 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL26 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CCL19 Biologics Sequence Review Report 2026: C-C motif chemokine 19 Similarity and Patent-Risk Signals
8 min read
CCL19 Biologics Sequence Review Report 2026: C-C motif chemokine 19 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL19 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CCL20 Biologics Sequence Review Report 2026: C-C motif chemokine 20 Similarity and Patent-Risk Signals
8 min read
CCL20 Biologics Sequence Review Report 2026: C-C motif chemokine 20 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL20 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CCL2 Biologics Sequence Review Report 2026: C-C motif chemokine 2 Similarity and Patent-Risk Signals
8 min read
CCL2 Biologics Sequence Review Report 2026: C-C motif chemokine 2 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CCL18 Biologics Sequence Review Report 2026: C-C motif chemokine 18 Similarity and Patent-Risk Signals
8 min read
CCL18 Biologics Sequence Review Report 2026: C-C motif chemokine 18 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL18 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CCL14 Biologics Sequence Review Report 2026: C-C motif chemokine 14 Similarity and Patent-Risk Signals
8 min read
CCL14 Biologics Sequence Review Report 2026: C-C motif chemokine 14 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL14 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CCL1 Biologics Sequence Review Report 2026: C-C motif chemokine 1 Similarity and Patent-Risk Signals
8 min read
CCL1 Biologics Sequence Review Report 2026: C-C motif chemokine 1 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →